Document Type : Original Articles
Authors
- Zohreh Mazloom 1
- Seyedeh Maryam Abdollahzadeh 1
- Mohammad Hossein Dabbaghmanesh 2
- Abbas Rezaianzadeh 3
1 Department of Clinical Nutrition, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
2 Department of Endocrine and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
3 Research Center for Health Sciences, Department of Epidemiology, Shiraz University of Medical Sciences, Shiraz, Iran.
Abstract
Background: Diabetes Mellitus (DM) is closely associated with reduction of antioxidant defense system. In the present study, we investigated the antioxidant effect of quercetin supplementation on the glycemic control, lipid profile and oxidative stress indices in patients with type 2diabetes. Methods: Forty seven patients with type 2 diabetes, aged 30-60 years old, were randomly assigned to supplement their daily diet with either an oral quercetin (250 mg/d) or identical placebo (cellulose) capsules for 8 weeks. The supplements were provided to the patients biweekly. Anthropometric data as well as glycemic indices, lipid profile and oxidative stress parameters of blood samples were determined at the baseline and endpoint of the study. Results: Dietary quercetin supplementation significantly improved the total antioxidant capacity (TAC) in the intervention group, when compared to the placebo group (P=0.043). It also resulted in a statistically significant reduction in serum concentration of atherogenic oxidized LDL (ox-LDL) (P0.05). Conclusions: Oral quercetin supplementation was beneficial in improving the antioxidant status of patients with type 2 diabetes while having no other significant effect on glycemic control and lipid profile; however, conducting further studies, using different doses, on the glycemiccontrol and/or hyperlipidemia of thepopulation seems to be valuable. Trial Registration Number: IRCT2012101911168N
Keywords
- Moghissi ES, Korytkowski MT, DiNardo M, Einhorn
- D, Hellman R, Hirsch IB, et al. American Association
- of Clinical Endocrinologists and American Diabetes
- Association Consensus Statement on Inpatient
- Glycemic Control. Diabetes Care. 2009; 32(6): 1119-31.
- American Diabetes Association. Standards of Medical
- Care in Diabetes-2009. Diabetes Care 2009; 32: S13-61.
- Khatib OMN editor. Guidelines for the prevention,
- management and care of diabetes mellitus. 1st ed.
- World Health Organization, Regional Office for the
- Eastern Mediterranean; 2006.
- Shen GX. Lipid Disorders in Diabetes Mellitus
- and Current Management. Current Pharmaceutical
- Analysis 2007; 3: 17-24.
- Agardh E, Allebeck P, Hallqvist J, Moradi T, Sidorchuk
- A. Type 2 diabetes incidence and socio-economic
- position: a systematic review and meta-analysis. Int
- J Epidemiol 2011; 40: 804-18.
- Heinisch BB, Francesconi M, Mittermayer F, Schaller
- G, Gouya G, Wolzt M, et al. Alpha-lipoic acid improves vascular endothelial function in patients with type 2
- diabetes: a placebo-controlled randomized trial. Eur
- J Clin Invest 2010; 40: 148-54.
- Lai MH. Antioxidant effects and insulin resistance
- improvement of chromium combined with vitamin C
- and E supplementation for type 2 diabetes mellitus. J
- Clin Biochem Nutr 2008; 43: 191-8.
- Brasnyo P, Molnar GA, Mohas M, Marko L, Laczy B,
- Cseh J, et al. Resveratrol improves insulin sensitivity,
- reduces oxidative stress and activates the Akt pathway
- in type 2 diabetic patients. Br J Nutr 2011; 106: 383-9.
- Roussel AM, Kerkeni A, Zouari N, Mahjoub S,
- Matheau JM, Anderson RA. Antioxidant effects of
- zinc supplementation in Tunisians with type 2 diabetes
- mellitus. J Am Coll Nutr 2003; 22: 316-21.
- Dias AS, Porawski M, Alonso M, Marroni N, Collado
- PS, Gonza´ lez-Gallego J. Quercetin decreases oxidative
- stress, NF-κBactivation, and iNOS overexpression in
- liver of streptozotocin-induced diabetic rats. J Nutr
- ; 135: 2299-304.
- Ajay M, Achike FI, Mustafa AM, Mustafa MR. Effect
- of quercetin on altered vascular reactivity in aortas
- isolated from streptozotocin-induced diabetic rats.
- Diabetes Res Clin Pr 2006; 73: 1-7.
- Anderson RA. Chromium and polyphenols from
- cinnamon improve insulin sensitivity. Proc Nutr Soc
- ; 67: 48-53.
- Anderson RA, Roussel AM, Zouari N, Mahjoub S,
- Matheau JM, Kerkeni A. Potential antioxidant effects
- of zinc and chromium supplementation in people with
- type 2 diabetes mellitus. J Am Coll Nutr 2001; 20:
- -8.
- Duarte J, PeÃrez-Palencia R, Vargas F, Ocete MA,
- PeÃrez-Vizcaino F, Zarzuelo A, et al. Antihypertensive
- effects of the flavonoid quercetin in spontaneously
- hypertensive rats. Br J Pharmacol 2001; 133: 117-24.
- Egert S, Wolffram S, Schulze B, Langguth P,
- Hubbermann EM, Schwarz K, et al. Enriched
- cereal bars are more effective in increasing plasma
- quercetincompared with quercetin from powder-filled
- hard capsules. Br J Nutr 2011; 1-8.
- Edwards RL, Lyon T, Litwin SE, Rabovsky A, Symons
- JD, JaliliT. Quercetin Reduces Blood Pressure in
- Hypertensive Subjects. J Nutr 2007; 137: 2405-11.
- Garcı´a-Lafuente A, Guillamo´n E, Villares A, Rostagno
- MA, Martı´nezJA. Flavonoids as anti-inflammatory
- agents: implications in cancer and cardiovascular
- disease. Inflamm Res 2009; 58: 537-52.
- Loke WM, Hodgson JM, Proudfoot JM, McKinley
- AJ, P uddey I B, Croft K D. P ure d ietary flavonoids
- quercetin and (_)-epicatechin augment nitric oxide
- products and reduce endothelin-1 acutely in healthy
- men. Am J ClinNutr 2008; 88: 1018-25.
- Egert S, Bosy-Westphal A, Seiberl J, Ku¨rbitz C,
- Settler U, Plachta-Danielzik S, et al. Quercetin reduces
- systolic blood pressure and plasma oxidised low-density
- lipoprotein concentrations in overweight subjects with
- a high-cardiovascular disease risk phenotype: a doubleblinded,
- placebo-controlled cross-over study. Br J Nutr
- ; 102: 1065-74.
- Pandey KB, Rizvi SI. Protection of protein carbonyl
- formation by quercetinin erythrocytes subjected to
- oxidative stress. Med Chem Res 2010; 19: 186-92.
- Kim JH, Kang MJ, Choi HN, Jeong SM, Lee YM,
- Kim JI. Quercetin attenuates fasting and postprandial
- hyperglycemia in animal models of diabetes mellitus.
- Nutr Res Pract 2011; 5: 107-11.
- Ghaffari MA, Mojab S. Influence of flavonolsas in vitro
- on low density lipoprotein glycation. Iran Biomed J
- ; 11: 185-91.
- Bhutada P, Mundhada Y, Bansod K, Bhutada C, Tawari
- S, Dixit P, et al. Ameliorative effect of quercetin on
- memory dysfunction in streptozotocin-induced diabetic
- rats. Neurobiol Learn Mem 2010; 94: 293-302.
- Liang W, Luo Z, Ge S, Li M, Du J, Yang M, et al. Oral
- administration of quercetin inhibits bone loss in rat
- model of diabetic osteopenia. Eur J Pharmacol 2011;
- doi:10.1016/j.ejphar.2011.08.014.
- Namvaran F, Azarpira N, Rahimi-moghaddam P,
- Dabbaghmanesh, MH. Polymorphism of peroxisome
- proliferator-activated receptor γ (PPARγ) Pro12Ala in
- the Iranian population: Relation with insulin resistance
- and response to treatment with pioglitazone in type 2
- diabetes. Eur J Pharmacol 2011; 671(1-3): 1-6.
- BootsA, Wilms LC, Swennen ELR, Kleinjans JCS, Bast
- A, Haenen GRM. In vitro and ex vivo anti-inflammatory
- activity of quercetin in healthy volunteers. Nutrition
- ; 24: 703-10.
- Machha A, Achike FI, Mustafa AM, Mustafa MR.
- Quercetin, a flavonoid antioxidant, modulates
- endothelium-derived nitric oxide bioavailability in
- diabetic rat aortas. Nitric Oxide 2007; 16: 442-7.
- Serafini M, DelRio D. Understanding the association
- between dietary antioxidants, redox status and disease:
- is the Total Antioxidant Capacity the right tool? Redox
- Rep 2004; 9(3): 145-52.
- Prochazkova D, Boušova I, Wilhelmova N. Antioxidant
- and prooxidant properties of flavonoids. Fitoterapia
- ; 82: 513-23.
- Pfeuffer M, Auinger A, Bley U, Kraus-Stojanowic I,
- Laue C, Winkler P, et al. Effect of quercetin on traits
- of the metabolic syndrome, endothelial function and
- inflammatory parameters in men with different APOE
- isoforms. Nutr Metab Cardiovas 2011; doi:10.1016/
- j.numecd.2011.08.010.
- Rodrigo R, Miranda A, Vergara L. Wine and oxidative
- stress: Up-to-date evidence of the effects of moderate
- wine consumption on oxidative damage in humans.
- Atherosclerosis 2010; 208: 297â304.
- Knekt P, Kumpulainen J, Järvinen R, Rissanen H,
- Heliövaara M, Reunanen A, et al. Flavonoid intake
- and risk of chronic diseases. Am J Clin Nutr 2002;
- : 560-8.
- LukaÄinova A, MojžiÅ¡ J, BeÅaÄka R, Keller J, Maguth T, Kurila P, et al. Preventive effects of flavonoids on
- alloxan-induced diabetes mellitus in rats. Acta Vet
- Brno 2008; 77: 175-82.
- Kannappan S, Anuradha CV. Insulin sensitizing actions
- of fenugreek seed polyphenols, quercetin & metformin
- in a rat model. Indian J Med Res 2009; 129: 401-8.
- Jo SH, Ka EH, Lee HS, Apostolidis E, Jang HD,
- Kwon YI. Comparison of Antioxidant Potential and
- Rat intestinal α-Glucosidases inhibitory Activities
- of Quercetin, Rutin, and Isoquercetin. IJARNP 2010;
- (4): 52-60.
- Lee KH, Park E, Lee HJ, Kim MO, Cha YJ, Kim JM,
- et al. Effects of daily quercetin-rich supplementation
- on cardiometabolic risks in male smokers. Nutr Res
- Pract 2011; 5(1): 28-33.
- NuralievI, Avezov GA. Efficacy of quercetin in alloxin
- diabetes. Eksp Klin Farmakol 1992; 55: 42-4.